RATIONALE 311: tislelizumab plus concurrent chemoradiotherapy for localized esophageal squamous cell carcinoma

Future Oncology, Ahead of Print.

Source: Future Oncology - July 16, 2021 Category: Cancer & Oncology Authors: Rong Yu Wenqing Wang Tao Li Jiancheng Li Kuaile Zhao Weihu Wang Long Liang Haishan Wu Tashan Ai Wei Huang Liyun Li Wentao Yu Chenlu Wei Yidi Wang Wei Shen Zefen Xiao Source Type: research